Summary
Background Subthreshold depression is a risk factor for major depression and is associated with increased morbidity and mortality, especially in poorly resourced settings. There is emerging evidence that digital interventions may be effective at improving depressive symptoms in High Income Countries but not Low-and Middle-Income settings. We aimed to evaluate the effectiveness of the Viva Vida digital intervention at improving symptoms of subthreshold depression among older adults in socioeconomically deprived settings in Brazil.
Methods PRODIGITAL was a single blind, two-arm, individually randomised controlled trial conducted in 46 primary care clinics in Guarulhos, Brazil. Individuals aged 60+ years were randomly contacted by phone for a screening assessment. Those who presented with anhedonia and/or depressed mood (Patient Health Questionnaire (PHQ)-2), and who subsequently scored between 5 and 9 on the PHQ-9 were invited to participate. The intervention (Viva Vida) arm received a self-help fully automated programme sent via WhatsApp with no support from healthcare professionals. Forty-eight audio and visual messages based on psychoeducation and behavioural activation approaches were delivered over six weeks. The control arm received a single message with information about depression. The primary outcome was the PHQ-9 at three months’ follow-up. All primary analyses were performed according to allocated arm with imputed data. The trial is registered with ReBEC, RBR-6c7ghfd.
Findings Participants were recruited between 8 September 2021 and 19 August 2022. Of the 454 participants enrolled, 223 were randomised to the intervention arm and 231 to receive the single message. A total of 385 (84·8%) completed the three-month follow-up assessment; no difference in mean PHQ-9 scores between the arms (adjusted difference: -0·61; 95% CI: -1·76, 0·53; p=0·290) was observed.
Interpretation These results demonstrate that a fully automated digital programme did not help to improve subthreshold depressive symptoms amongst older adults. More research is needed to understand how such interventions can be adapted to reduce depressive symptoms as well as prevent against major depression in low-resourced settings.
Funding São Paulo Research Foundation and Joint Global Health Trials
Research in context Evidence before this study
We searched PubMed for randomised controlled trials on Oct 20, 2023, using the search terms (((((((digital) OR (internet)) OR (web)) OR (mobile)) OR (e-health) OR (technology) AND (((subthreshold) OR (subclinical)) OR (subsyndromal))) AND (((depression) OR (depressive)))) AND (((older) OR (elderly) OR (senior))). We did not apply any restrictions on languages or date of publication. Two studies assessing a fully automated digital intervention for subthreshold depression were found. An internet-based cognitive behavioural therapy (iCBT) was delivered to adults aged 50+ years in the Netherlands, whilst automated emails using self-help behaviour strategies (Mood Memos) was sent to adults from 18 to 78 years (mean age of 36 years) in Australia. The interventions showed improvement on depressive symptoms at ten (iCBT) and six weeks (Mood Memos). Like the Viva Vida, one study conducted with adults in China used a messaging application (WeChat). However, WeChat offers more features, and the iCBT programme was guided by clinical psychologists.
Added value of this study We report a self-help fully automated digital psychosocial intervention for subthreshold depression among older adults in Brazil. To the best of our knowledge, this is the first psychosocial intervention of this kind in a low-and middle-income country. The intervention was designed to be user-friendly and accessible to a population with low literacy and limited digital skills. While a significant portion of participants engaged with the programme by opening most of the messages, we did not observe any difference in improving depressive symptoms.
Implications of all the available evidence Fully automated digital interventions with no support of health or lay professionals are usually low cost and can easily be scaled up. Consequently, they have the potential to improve access to care and help reduce the mental health treatment gap in an affordable way. When tailored to socioeconomically vulnerable individuals, these interventions can also help promote more equitable access to care. Future studies should focus on understanding how to adapt such interventions to be effective for subthreshold depression.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The protocol is registered with Registro Brasileiro de Ensaios Clinicos (ReBEC) (RBR-6c7ghfd)
Funding Statement
This study was funded by the Sao Paulo Research Foundation (process number 2017/50094 2) and the Joint Global Health Trials initiative, jointly funded by the Department of Health and Social Care (DHSC), the Foreign, Commonwealth & Development Office (FCDO), the Medical Research Council (MRC) and Wellcome (process number MR/R006229/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was authorised by the Secretaria da Saude do Municipio de Guarulhos and approved by the Ethics Committee of the Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo HCFMUSP (CAPPesq, CAEE: 32078720.0.0000.0068, first approved on 09 July 2020). The Statistical Analysis Plan version 1.0 was submitted to the Kings College London repository. The trial was registered on 21 October 2021 (submitted on 03 August 2021) at the Registro Brasileiro de Ensaios Clinicos (ReBEC, ensaiosclinicos.gov.br), RBR 6c7ghfd. Recruitment of participants began in September 2021.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data will be available for reasonable requests from authors approximately one year after publication
